CoChat

Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems

Open access
Rowe, Theresa A, Jacapraro, Janet S, Rastegar, Darius A · 2012 · Addiction Science & Clinical Practice

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions. METHODS: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit. RESULTS: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year. CONCLUSIONS: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1940-0640-7-22

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 38

Metadata

Authors
Rowe, T. A., Jacapraro, J. S., & Rastegar, D. A.
Affiliations
  • Yale University (US)
  • University of Maryland, Baltimore (US)
  • Johns Hopkins University (US)
Corresponding author
Rowe, Theresa A
Venue
Addiction Science & Clinical Practice
Published
2012-10-29
Volume
7
Issue
1
Pages
22-22
ISSN
  • 1940-0632 (ISSN-L)
  • 1940-0640
OpenAlex
W1990275197
Cited by
36
References
27
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3
FWCI
1.24
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Addiction Science & Clinical Practice (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Family Practice › Primary Care and Health Outcomes
Keywords
buprenorphine, opioid use disorder, primary care, sublingual buprenorphine, chronic disease, comorbidities, underdiagnosis, treatment initiation, opioid use disorder treatment
MeSH terms
Adult, Buprenorphine, Chronic Disease, Female, Humans, Insurance Claim Review, Male, Middle Aged, Narcotic Antagonists, Opioid-Related Disorders, Primary Health Care, Retrospective Studies, Socioeconomic Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems. https://app.cochat.ai/papers/10.1186/1940-0640-7-22
The paper
Rowe, T. A., Jacapraro, J. S., & Rastegar, D. A. (2012). Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems. Addiction Science & Clinical Practice. https://doi.org/10.1186/1940-0640-7-22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.